Clinical Trial Update: Development of Childhood Anti-Influenza Immunity [Phase 4]

View source ↗

Summary

Phase 4 trial update on developing childhood anti-influenza immunity; completed with results posted in 2022.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Influenza Immunisation

Snippet

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID) | Conditions: Influenza, Influenza Immunisation | Phase 4 | Status: COMPLETED | Results posted: 2022-03-18